Effect of empaglifozin on 24-hour blood pressure, brachyal endothelial dysfuncton, and left ventricular diastolic function, in patients with type-2 diabetes mellitus

Treatment with empaglifozin in diabetic patients produce clinically meaningful reductions in 24-hour brachial pressure, improve endothelial function and has an positive effect on left ventricular diastolic function. Besides Improvement in glycemic control, the positive effect on left ventricular function and vascular function and reactivity, may contribute to the cardiovascular benefits of the medication.